AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2017
Jun 2, 2017
32163_dirs_2017-06-02_01fcf7f9-f8b9-457a-ba16-155886c59806.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2017-05-31
Reporting Person: Ciaffoni Joseph (Chief Operating Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| No securities beneficially owned | 0 | Direct |
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26